However when all these factors were added to the base clinical model and a backwards stepwise selection carried out for the non-clinical variables, only IDH1 mutation retained independent statistical significance (Table 3, model 1), indicating that, after accounting for tumour grade, age, sex and performance status, IDH1 mutation was associated with better prognosis. The gene discussed is IDH1; the disease is neoplasm.